| Health Care Technology Industry | Healthcare Sector | Mr. Larry Abensur CEO | XMUN Exchange | FR0011005933 ISIN |
| France Country | 454 Employees | 16 May 2022 Last Dividend | - Last Split | - IPO Date |
Biosynex SA is a dynamic entity in the medical diagnostics industry, dedicated to the design, manufacture, and distribution of rapid diagnostic tests both in its home country of France and on an international scale. The company specializes in providing a comprehensive range of medical devices aimed at in vitro diagnosis, covering various essential fields such as bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women's health. Recognized for its significant contributions during the COVID-19 pandemic, Biosynex SA adapted swiftly to global needs by offering specialized tests and instruments to combat the virus. Founded in 1993 and headquartered in Illkirch-Graffenstaden, France, Biosynex SA has established itself as a trusted partner in healthcare, catering to the needs of biology and medical analysis laboratories, hospitals, pharmacies, and even consumer markets such as hyper and supermarkets. The company's commitment to enhancing healthcare outcomes is further emphasized through its extensive international export activities, underscoring its global impact and ambition.
These products are designed for efficient screening, diagnosis, and prevention in critical health areas including bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women’s health. Biosynex SA leverages sophisticated technologies to offer rapid and reliable results, supporting medical professionals in making informed decisions swiftly.
In response to the global pandemic, Biosynex SA expanded its product range to include COVID-19 diagnostic tools. These include rapid tests for swift identification of the virus, as well as various instruments essential for testing procedures. The company’s agile adaptation to the pandemic underscores its commitment to public health and safety.
Understanding the growing demand for personal health monitoring, Biosynex SA offers a range of self-tests and self-measurement products. These include thermometers, oximeters, and blood pressure monitors, facilitating individuals to monitor their health conveniently and accurately from the comfort of their homes.
Beyond diagnostic solutions, Biosynex SA addresses broader healthcare needs by providing oral care and various medical aid products. These offerings underline the company’s commitment to comprehensive health and well-being, catering to both medical institutions and individual consumers.